Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
group | 0.260 | None | 1.000 | 6 | 0 | 2003 | 2017 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.500 | None | 1.000 | 4 | 0 | 2005 | 2016 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2008 | 2014 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.210 | None | 1.000 | 3 | 0 | 2003 | 2018 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2008 | 2012 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2011 | 2014 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.260 | None | 1.000 | 3 | 0 | 2005 | 2018 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.986 | 2 | 0 | 2000 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2011 | 2012 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
dystrophin | 0.423 | 0.923 | 1.00 |
|
disease | 1.000 | strong | 0.980 | 2 | 0 | 1981 | 2020 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2008 | 2014 | ||||||||
|
coagulation factor VIII | 0.542 | 0.769 | 1.00 |
|
disease | 1.000 | definitive | 0.983 | 2 | 0 | 1977 | 2020 | ||||||||
|
fibrillin 1 | 0.417 | 0.846 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2006 | 2006 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.220 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.230 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2009 | 2012 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
huntingtin | 0.548 | 0.654 | 1.00 |
|
disease | 1.000 | limited | 0.987 | 2 | 0 | 1993 | 2020 | ||||||||
|
insulin like growth factor 2 receptor | 0.518 | 0.731 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1998 | 2004 | ||||||||
|
microtubule associated protein 1B | 0.628 | 0.500 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2001 | 2003 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2000 | 2012 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.230 | None | 0.800 | 2 | 0 | 1998 | 2013 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.250 | None | 0.857 | 2 | 0 | 1998 | 2018 |